HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

William J McBride Selected Research

DOTA- tyrosyl- lysyl(histaminyl- succinyl- glycyl)- glutamyl- lysyl(histaminyl- succinyl- glycyl)amide

1/2017α- Versus β-Emitting Radionuclides for Pretargeted Radioimmunotherapy of Carcinoembryonic Antigen-Expressing Human Colon Cancer Xenografts.
2/2015Pretargeted immunoPET of prostate cancer with an anti-TROP-2 x anti-HSG bispecific antibody in mice with PC3 xenografts.
8/2014Predictive patient-specific dosimetry and individualized dosing of pretargeted radioimmunotherapy in patients with advanced colorectal cancer.
11/2010Pretargeted 177Lu radioimmunotherapy of carcinoembryonic antigen-expressing human colonic tumors in mice.
4/2010Pretargeted immuno-positron emission tomography imaging of carcinoembryonic antigen-expressing tumors with a bispecific antibody and a 68Ga- and 18F-labeled hapten peptide in mice with human tumor xenografts.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


William J McBride Research Topics

Disease

36Neoplasms (Cancer)
01/2017 - 01/2003
19Alcoholism (Alcohol Abuse)
12/2020 - 01/2002
7Colonic Neoplasms (Colon Cancer)
01/2017 - 11/2005
6Prostatic Neoplasms (Prostate Cancer)
02/2015 - 06/2012
5Binge Drinking
01/2018 - 10/2012
4Colorectal Neoplasms (Colorectal Cancer)
06/2015 - 11/2005
4Non-Hodgkin Lymphoma (Lymphosarcoma)
05/2010 - 09/2007
3Tobacco Use Disorder (Nicotine Dependence)
06/2019 - 02/2015
3Genetic Predisposition to Disease (Genetic Predisposition)
01/2016 - 12/2004
3Pancreatic Neoplasms (Pancreatic Cancer)
12/2009 - 01/2008
2Filarial Elephantiasis (Lymphatic Filariasis)
01/2021 - 11/2018
2Carcinoma (Carcinomatosis)
06/2015 - 10/2012
2Decapitation
02/2014 - 03/2010
2Lymphoma (Lymphomas)
10/2009 - 09/2007
2Renal Cell Carcinoma (Grawitz Tumor)
09/2005 - 09/2003
1Infections
11/2018
1Filariasis
11/2018
1Body Weight (Weight, Body)
01/2017
1Neoplasm Metastasis (Metastasis)
11/2014
1Inflammation (Inflammations)
04/2010
1Burkitt Lymphoma (Burkitt's Lymphoma)
03/2009
1B-Cell Lymphoma (Lymphoma, B Cell)
07/2008
1Neoplasm Micrometastasis
09/2007
1Glioblastoma (Glioblastoma Multiforme)
09/2006

Drug/Important Bio-Agent (IBA)

28Peptides (Polypeptides)IBA
01/2017 - 01/2003
16HaptensIBA
02/2015 - 11/2005
13Ethanol (Ethyl Alcohol)IBA
01/2018 - 09/2002
10Carcinoembryonic AntigenIBA
01/2017 - 10/2005
8Radioisotopes (Radionuclides)IBA
01/2017 - 01/2003
7Monoclonal AntibodiesIBA
01/2017 - 09/2003
7Immunoglobulin G (IgG)IBA
11/2015 - 10/2005
7AntibodiesIBA
06/2012 - 09/2003
6Histamine (Histamine Dihydrochloride)FDA Link
01/2017 - 11/2005
6Glycine (Aminoacetic Acid)FDA LinkGeneric
01/2017 - 11/2005
6AntigensIBA
02/2015 - 01/2003
5NicotineFDA Link
06/2019 - 05/2012
5DOTA- tyrosyl- lysyl(histaminyl- succinyl- glycyl)- glutamyl- lysyl(histaminyl- succinyl- glycyl)amideIBA
01/2017 - 04/2010
5AcidsIBA
02/2010 - 09/2003
5salsolinolIBA
02/2010 - 01/2002
4Dopamine (Intropin)FDA LinkGeneric
02/2015 - 02/2008
4Pentetic Acid (DTPA)FDA LinkGeneric
02/2010 - 09/2003
3procaine isothiocyanate (PRIT)IBA
01/2017 - 11/2010
3Bispecific AntibodiesIBA
02/2015 - 10/2005
3Therapeutic UsesIBA
12/2012 - 09/2003
3Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2012 - 10/2006
3AcetaldehydeIBA
02/2010 - 01/2002
2RNA (Ribonucleic Acid)IBA
01/2018 - 02/2015
21,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
01/2017 - 11/2014
2Proteins (Proteins, Gene)FDA Link
01/2016 - 01/2004
2Immunoconjugates (Immunoconjugate)IBA
11/2015 - 06/2015
2Irinotecan (Camptosar)FDA LinkGeneric
11/2015 - 06/2015
2Bombesin Receptors (Bombesin Receptor)IBA
12/2014 - 06/2012
2A-factor (Streptomyces)IBA
02/2008 - 03/2003
2Immunoglobulin Fab FragmentsIBA
05/2006 - 10/2005
1Atrial Natriuretic Factor (ANF)IBA
12/2020
1CannabinoidsIBA
10/2020
1Hemoglobins (Hemoglobin)IBA
01/2017
1CreatinineIBA
01/2017
1Glutamic Acid (Glutamate)FDA Link
01/2016
1EnzymesIBA
01/2016
1Neurotransmitter Agents (Neurotransmitter)IBA
01/2016
1Glutamate Receptors (Glutamate Receptor)IBA
01/2016
1sacituzumab govitecanIBA
11/2015
1labetuzumab govitecanIBA
06/2015
1Topoisomerase I InhibitorsIBA
06/2015
1labetuzumabIBA
06/2015
1Bevacizumab (Avastin)FDA Link
06/2015
1CotinineIBA
02/2015
1IntegrinsIBA
05/2013
11- (1,3- carboxypropyl)- 4,7- carboxymethyl- 1,4,7- triazacyclononaneIBA
05/2013
1arginyl-glycyl-aspartic acidIBA
05/2013
1Phosphates (Orthophosphate)IBA
12/2012
1Immunoglobulin FragmentsIBA
06/2012
1IsotopesIBA
06/2012
1BombesinIBA
06/2012
1Cocaine (Cocaine HCl)IBA
10/2011
1Neoplasm Antigens (Tumor Antigens)IBA
05/2010
1Somatostatin Receptors (Somatostatin Receptor)IBA
03/2010
1clivatuzumabIBA
12/2009
1MucinsIBA
12/2009
1EpitopesIBA
12/2009
1GemcitabineFDA Link
12/2009
1Antiviral Agents (Antivirals)IBA
10/2009
1triazacyclononaneIBA
06/2009
11,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA
06/2009
1Inosine Monophosphate (IMP)IBA
06/2009
1SolutionsIBA
06/2009
1veltuzumabIBA
03/2009
1peptide 74IBA
03/2009
1CatecholaminesIBA
03/2008
1FluorineIBA
02/2008
1Fibronectins (Fibronectin)IBA
09/2006
1Naltrexone (ReVia)FDA LinkGeneric
01/2006
1N-acetylphenylalanyllysineIBA
10/2005

Therapy/Procedure

14Radioimmunotherapy
01/2017 - 09/2003
11Therapeutics
06/2015 - 01/2003
2Mass Drug Administration
01/2021 - 11/2018
1Drug Substitution
06/2015
1Computer-Assisted Surgery (Image Guided Surgery)
11/2014
1Radiotherapy
09/2006